Trial Profile
A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus on Background Treatment With Pioglitazone.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 21 Jan 2019
Price :
$35
*
At a glance
- Drugs Dutogliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Registrational
- Sponsors Forest Laboratories
- 09 Sep 2010 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 07 Jul 2010 Additional locations (Germany, Belarus, Lithuania, Romania) identified as reported by ClinicalTrials.gov.
- 07 Jul 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.